Annual report [Section 13 and 15(d), not S-K Item 405]

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.25.1
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Accounts payable:    
Clinical and regulatory expenses $ 452 $ 696
Professional fees 904 721
Selling expenses 1,553 1,498
Manufacturing costs 706 914
Non-employee director compensation 966 766
Other vendors 594 518
Total accounts payable 5,175 5,113
Accrued interest payable, related parties 1,145 542
Accrued interest payable 2,874 3,122
Accrued expenses:    
Payroll expenses 323 1,270
Government rebates and other rebates 7,229 5,881
Due to customers 15 844
Other accrued expenses 165 179
Total accrued expenses 7,732 8,174
Total accounts payable and accrued expenses $ 16,926 $ 16,951